The BusinessWeek 50 Ranking
30
Boston Scientific
Boston Scientific got a lot of bad press last summer when it was forced to recall about 100,000 of its revolutionary new Taxus drug-coated coronary stents. But the trouble proved to be temporary as stent sales soared 345%, to $2.4 billion, helping earnings more than double. The reason: Most doctors believe Taxus cuts the odds that coronary arteries will reclog after angioplasty. But with the stock down from its peak over concerns about stent competition, the Natick (Mass.) company is spending heavily to expand into promising new businesses, such as spinal cord stimulation, which is used to help manage pain.
Company Info
| 2004 Rank | 60 |
| STOCK INFO | BSX |
| Market Value | $27.6 BILLION |
| Total Return | (1-yr.) -20.0%
(3-yr.) 192.1% |
| 2004 sales | $5.6 BILLION |
| Sales Growth | (1-yr.) 62%
(3-yr.) 27.2% |
| Net income | $1.1 BILLION |
| Net Income Growth | (1-yr.) 125%
(3-yr.) 68.7% |
| Net Margin* | 18.9% |
| Return on Equity* | 26.4% |
| Industry | HEALTH-CARE EQUIPMENT & SERVICES |
| CORPORATE WEB SITE | |
More in S&P 500 Companies Scoreboard >
*Trailing 12 months
Company data as of 2/28/05 provided by Standard & Poor's Compustat
Rewiring the Body
J&J: Don't Stop the Dealmaking Now
Boston Scientific: Anemic, For Now
James Tobin: Feeling Better
Why Boston Scientific Is Pumping Again
The Wrong Way to Run a Recall
Company Snapshot
Boston Scientific Corporation engages in the development, manufacture, and marketing of medical devices that are used in interventional medical specialties. The company's products are offered by two groups, Cardiovascular and Endosurgery. The Cardiovascular organization provides products and technologies for use in interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, and neurovascular procedures. The Endosurgery organization provides products and technologies for use in oncology, endoscopy, urology, and gynecology procedures. Boston Scientific conducts its sales through its direct sales force, and a network of distributors and dealers. The company was founded by Mr. John E. Abele and Mr. Peter M. Nicholas in 1979. Boston Scientific is headquartered in Natick, Massachusetts.
No. of Employees
NA
Data provided by 
